A molecular-field-based similarity study of non-nucleoside HIV-1 reverse transcriptase inhibitors

This article describes a molecular-field-based similarity method for aligning molecules by matching their steric and electrostatic fields and an application of the method to the alignment of three structurally diverse non-nucleoside HIV-1 reverse transcriptase inhibitors. A brief description of the method, as implemented in the program MIMIC, is presented, including a discussion of pairwise and multi-molecule similarity-based matching. The application provides an example that illustrates how relative binding orientations of molecules can be determined in the absence of detailed structural information on their target protein. In the particular system studied here, availability of the X-ray crystal structures of the respective ligand–protein complexes provides a means for constructing an 'experimental model' of the relative binding orientations of the three inhibitors. The experimental model is derived by using MIMIC to align the steric fields of the three protein P66 subunit main chains, producing an overlay with a 1.41 Å average rms distance between the corresponding Cα's in the three chains. The inter-chain residue similarities for the backbone structures show that the main-chain conformations are conserved in the region of the inhibitor-binding site, with the major deviations located primarily in the 'finger' and RNase H regions. The resulting inhibitor structure overlay provides an experimental-based model that can be used to evaluate the quality of the direct a priori inhibitor alignment obtained using MIMIC. It is found that the 'best' pairwise alignments do not always correspond to the experimental model alignments. Therefore, simply combining the best pairwise alignments will not necessarily produce the optimal multi-molecule alignment. However, the best simultaneous three-molecule alignment was found to reproduce the experimental inhibitor alignment model. A pairwise consistency index has been derived which gauges the quality of combining the pairwise alignments and aids in efficiently forming the optimal multi-molecule alignment analysis. Two post-alignment procedures are described that provide information on feature-based and field-based pharmacophoric patterns. The former corresponds to traditional pharmacophore models and is derived from the contribution of individual atoms to the total similarity. The latter is based on molecular regions rather than atoms and is constructed by computing the percent contribution to the similarity of individual points in a regular lattice surrounding the molecules, which when contoured and colored visually depict regions of highly conserved similarity. A discussion of how the information provided by each of the procedures is useful in drug design is also presented.

[1]  Gerhard Klebe,et al.  Different approaches toward an automatic structural alignment of drug molecules: Applications to sterol mimics, thrombin and thermolysin inhibitors , 1994, J. Comput. Aided Mol. Des..

[2]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1977, Journal of molecular biology.

[3]  Ramon Carbó Molecular Similarity and Reactivity , 1995 .

[4]  J. Adams,et al.  Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. , 1990, Science.

[5]  Ramón Carbó,et al.  Molecular similarity and reactivity : from quantum chemical to phenomenological approaches , 1995 .

[6]  Eamonn F. Healy,et al.  Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .

[7]  P. Mui,et al.  Crystal structure of nevirapine, a non-nucleoside inhibitor of HIV-1 reverse transcriptase, and computational alignment with a structurally diverse inhibitor. , 1992, Journal of medicinal chemistry.

[8]  Ramon Carbo,et al.  How similar is a molecule to another? An electron density measure of similarity between two molecular structures , 1980 .

[9]  G. Maggiora,et al.  A molecular field-based similarity approach to pharmacophoric pattern recognition. , 1997, Journal of molecular graphics & modelling.

[10]  T. Steitz,et al.  Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. , 1992, Science.

[11]  E. Clercq HIV resistance to reverse transcriptase inhibitors , 1994 .

[12]  Thomas Lengauer,et al.  Time-efficient flexible superposition of medium-sized molecules , 1997, German Conference on Bioinformatics.

[13]  Jordi Mestres,et al.  MIMIC: A molecular‐field matching program. Exploiting applicability of molecular similarity approaches , 1997 .

[14]  Andrew C. Good,et al.  Utilization of Gaussian functions for the rapid evaluation of molecular similarity , 1992, J. Chem. Inf. Comput. Sci..

[15]  A. Good,et al.  Structure-activity relationships from molecular similarity matrices. , 1993, Journal of medicinal chemistry.

[16]  Marvin Johnson,et al.  Concepts and applications of molecular similarity , 1990 .

[17]  J. A. Grant,et al.  A fast method of molecular shape comparison: A simple application of a Gaussian description of molecular shape , 1996, J. Comput. Chem..

[18]  M. Miranda,et al.  Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo [4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives. 3. , 1991, Journal of medicinal chemistry.

[19]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[20]  W. Schäfer,et al.  Non-nucleoside inhibitors of HIV-1 reverse transcriptase: molecular modeling and X-ray structure investigations. , 1993, Journal of medicinal chemistry.

[21]  Bernd Beck,et al.  The Inhibition of α-chymotrypsin predicted using theoretically derived molecular properties , 1996 .

[22]  Jean-Pierre Dubost,et al.  Une nouvelle approche des relations structure-activité: le «potentiel de lipophilie moléculaire» , 1986 .